Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
NCT ID: NCT05820919
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
456 participants
INTERVENTIONAL
2023-09-07
2027-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Sleep Quality for Nursing Home Residents With Dementia
NCT04533815
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease
NCT06045988
On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs
NCT04871698
The Healthy Patterns Sleep Study
NCT03682185
Couples Health Aging, Rhythms and Sleep Study
NCT05952284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is an incomplete stepped-wedge randomized controlled trial to test the impact and sustainability of the LOCK sleep program. In 24 community nursing homes (NHs)-eight from each of 3 national NH corporations-our multi-disciplinary team will examine these aims: (1) Implement the LOCK-based sleep program for residents with ADRD using the train-the-trainer model. (2) Estimate impact of the LOCK sleep program on sleep (primary outcome) and on psychotropic medication use, pain and analgesic medication use, and activities of daily living decline (secondary outcomes). (3) Examine factors, using mixed methods, associated with variation in the program's implementation and its sustainability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (each NH acts as its own control):
Each nursing home serves as its own control. Control data will be collected for 1 week (then the intervention will begin).
No intervention (control period/baseline data collection)
Each NH serves as its own control. During the control period, baseline data will be collected.
Intervention (all NHs receive the intervention):
The intervention arm includes a ten-week active intervention phase, then a five-week sustainment phase.
LOCK Sleep Program
The LOCK sleep program is a program that trains NH staff in a NH frontline staff huddling approach. It is derived from evidence supporting strengths-based learning, systematic observation, relationship-based teamwork, and efficiency. Staff learn how to work together as a team to collaboratively problem-solving about resident sleep challenges (e.g., evidence-based sleep promoting best practices and daytime meaningful activity best practices).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LOCK Sleep Program
The LOCK sleep program is a program that trains NH staff in a NH frontline staff huddling approach. It is derived from evidence supporting strengths-based learning, systematic observation, relationship-based teamwork, and efficiency. Staff learn how to work together as a team to collaboratively problem-solving about resident sleep challenges (e.g., evidence-based sleep promoting best practices and daytime meaningful activity best practices).
No intervention (control period/baseline data collection)
Each NH serves as its own control. During the control period, baseline data will be collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Residents who have a persistent bilateral resting tremor or paralysis in both arms (a subset of persons with Parkinson's disease and related significant tremor-causing diagnoses), due to actigraph measurement inaccuracies
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Lowell
OTHER
The University of Texas Health Science Center, Houston
OTHER
University of Texas at Austin
OTHER
Brown University
OTHER
University of Alabama, Tuscaloosa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
A. Lynn Snow
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynn Snow, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Alabama
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vivage/Beecan Corporation
Lakewood, Colorado, United States
National HealthCare Corporation
Murfreesboro, Tennessee, United States
Caraday Healthcare, LLC
San Marcos, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.